Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram-Negative Bacterial Infections: A Phase 1b, Open-Label, Single-Dose Clinical Trial.
Bradley JS, Makieieva N, Tøndel C, Roilides E, Kelly MS, Patel M, Vaddady P, Maniar A, Zhang Y, Paschke A, Chen LF. Bradley JS, et al. J Clin Pharmacol. 2023 Dec;63(12):1387-1397. doi: 10.1002/jcph.2334. Epub 2023 Sep 2. J Clin Pharmacol. 2023. PMID: 37562063 Clinical Trial.
Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram-negative bacterial infections.
Fornari C, Arrieta A, Bradley JS, Tout M, Magalhaes P, Auriol FK, Borella E, Piana C, Della Pasqua O, Vallespir BP, Mazzei P, Bokesch PM, Hoover R, Capriati A, Habboubi N. Fornari C, et al. Among authors: bradley js. Br J Clin Pharmacol. 2024 Oct;90(10):2597-2610. doi: 10.1111/bcp.16145. Epub 2024 Jun 26. Br J Clin Pharmacol. 2024. PMID: 38925918
Comparison of pediatric ventriculo-peritoneal shunt infections arising in antibiotic-impregnated and standard catheters: a multicenter observational study.
Robinson J, Balamohan A, Barton M, Lefebvre MA, Almadani A, Freire D, McAlpine A, Srigley J, Passarelli P, Bradley J, Davies D, Skar G, Viel-Theriault I, Khan S, Purewal R, LeSaux N, Bowes J, Hawkes M; Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). Robinson J, et al. World J Pediatr Surg. 2023 Jun 26;6(3):e000566. doi: 10.1136/wjps-2023-000566. eCollection 2023. World J Pediatr Surg. 2023. PMID: 37564927 Free PMC article. No abstract available.
Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old With Infections Treated With Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study.
Bradley JS, Orchiston E, Portsmouth S, Ariyasu M, Baba T, Katsube T, Makinde O. Bradley JS, et al. Pediatr Infect Dis J. 2024 Sep 4. doi: 10.1097/INF.0000000000004529. Online ahead of print. Pediatr Infect Dis J. 2024. PMID: 39230271
WHO global research priorities for antimicrobial resistance in human health.
Bertagnolio S, Dobreva Z, Centner CM, Olaru ID, Donà D, Burzo S, Huttner BD, Chaillon A, Gebreselassie N, Wi T, Hasso-Agopsowicz M, Allegranzi B, Sati H, Ivanovska V, Kothari KU, Balkhy HH, Cassini A, Hamers RL, Weezenbeek KV; WHO Research Agenda for AMR in Human Health Collaborators. Bertagnolio S, et al. Lancet Microbe. 2024 Aug 12:100902. doi: 10.1016/S2666-5247(24)00134-4. Online ahead of print. Lancet Microbe. 2024. PMID: 39146948 Free article. Review.
322 results